Medication info
Froxco Tablet (Ciprofloxacin Hydrochloride)

Froxco Tablet (Ciprofloxacin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride›291mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 199701894 · Notified 1997.02.26 · Insurance code 645602070

Summary

Main use
Treatment of bacterial infections (including urinary tract, respiratory, and skin infections)
Who takes it
Adults
Adult dose
○ Adults: The usual dose is 250 ~ 500 mg of ciprofloxacin per dose, taken orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days; treatment should continue for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only the serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be carefully monitored after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (including urinary tract, respiratory, and skin infections)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • external otitis
  • chronic cholesteatomatous otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
  • complicated urinary tract infections
View approved original text

This medication is used to treat various infections caused by bacteria such as Escherichia coli, Salmonella, Staphylococcus, and Streptococcus. It is particularly effective against respiratory infections except for acute bronchitis and community-acquired pneumonia. It is also used for treatment of ear, nose, and throat infections, bacterial prostatitis, urinary tract infections, gonococcal cervicitis, and urethritis. It is useful for a wide range of infections including gastrointestinal infections, biliary tract infections, skin and soft tissue infections, and osteoarticular infections. Specifically, this drug is a fluoroquinolone and should be used with caution in specific infections where no alternative therapies are available. Therefore, this medication is used for treating various bacterial infections.

How to take

Adult dose

○ Adults: The usual dose is 250 ~ 500 mg of ciprofloxacin per dose, taken orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days; treatment should continue for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only the serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be carefully monitored after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication may cause severe side effects such as tendonitis, tendon rupture, peripheral neuropathy, and central nervous system adverse reactions. Particularly, patients with myasthenia gravis should not use this medication as symptoms may worsen. If tendon pain or inflammation or nerve abnormality symptoms occur, stop using this medication immediately and consult a physician. This medication should only be used for specific infections and is recommended only when other treatment options are unavailable. Co-administration with corticosteroids should be avoided as it increases the risk of tendon rupture. It should not be used in pregnant or breastfeeding women, children under 18 years of age, patients with a history of hypersensitivity to this medication, patients with severe kidney impairment or history of seizures, elderly patients, and patients with myasthenia gravis should use it cautiously and must consult a physician before use. While taking this medication, immediately inform health personnel if symptoms such as seizures, mental changes, severe diarrhea, skin rash, visual disturbances, etc., occur. Additionally, this medication may interact with several drugs, so inform health personnel if taking any other medications. During the use of this medication, avoid strong sunlight or artificial UV exposure, and if any abnormal symptoms occur, stop taking it immediately. Diabetics requiring blood sugar control should carefully monitor blood sugar changes and receive immediate treatment if hypoglycemic symptoms occur. Elderly patients may have increased blood levels of this medication due to decreased kidney function, so dose adjustments and careful monitoring are necessary. In the case of overdose, kidney function must be closely monitored and necessary emergency measures should be taken. This medication should be stored out of the reach of children.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of severe myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, decreased hemoglobin, decreased hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reaction, angioedema, anaphylaxis, shock resembling anaphylaxis, serum sickness-like reaction, loss of appetite, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory reduction, loss of taste, tremors, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, collaborative disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, visual disturbances, color vision deficiency, diplopia, tinnitus, hearing loss, transient hearing loss, auditory damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distention, dyspepsia, pseudomembranous colitis, colitis associated with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function test, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and spasms, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, increased BUN, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, hypotension, chest tightness, myalgia, weakness, increased creatine kinase, elevated serum and urinary myoglobin, rhabdomyolysis, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is best to store the medication at room temperature, avoiding locations that are too hot or too cold.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.